Last reviewed · How we verify
fluocinolone acetonide intravitreal implant — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
fluocinolone acetonide intravitreal implant (fluocinolone acetonide intravitreal implant) — Bausch & Lomb Incorporated.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| fluocinolone acetonide intravitreal implant TARGET | fluocinolone acetonide intravitreal implant | Bausch & Lomb Incorporated | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- fluocinolone acetonide intravitreal implant CI watch — RSS
- fluocinolone acetonide intravitreal implant CI watch — Atom
- fluocinolone acetonide intravitreal implant CI watch — JSON
- fluocinolone acetonide intravitreal implant alone — RSS
Cite this brief
Drug Landscape (2026). fluocinolone acetonide intravitreal implant — Competitive Intelligence Brief. https://druglandscape.com/ci/fluocinolone-acetonide-intravitreal-implant. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab